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Editorial
World is experiencing a consistent and steady increase in the ageing
population with even higher proportional differences in the developed
countries. Increase in ageing populations is directly correlated with the
increased prevalence of age-related degenerative diseases of the central
nervous system (CNS) such as Alzheimer’s disease and various other
forms of dementias, stroke, Parkinson’s disease, retinal degenerative
disorders, Huntington’s’ disease, multiple sclerosis, psychiatric and
behavioural disorders amongst others [1]. The brain also undergoes a
number of functional and structural changes during ageing, even when
no contributing disease factors or genetic associations exist. A basic
trait of ageing is impairment in cellular signalling pathways mediating
requirement based cellular energy metabolism. This energy deficiency
exerts a chronic negative impact on cellular functions and manifests
itself in the form of degenerative processes in the CNS such as
decreased clearance and repair of damaged proteins and nucleic acids,
protein aggregates and other cellular debris. Brain and retina have
highest energy requirements compared to all other tissues making
them exceptionally vulnerable to metabolic stresses and therefore
availability of energy substrates leading to optimal energy homeostasis
is critical in these tissues [2]. Energy regulation in the brain is a major
research area that includes the study of the transformation of energy
substrates in cells and several associated biochemical processes like
respiration and production and utilization of energy in the form of
ATP. Since Peter D. Mitchell's discovery of ATP generation in the
cellular organelles like mitochondria [3], many groups have identified
various aspects of cellular survival, synaptic network formation,
development, plasticity and neuronal function as some of the critical
processes in living organisms that require steady supply of energy
generation and utilisation.
During the last decade multiple groups have provided evidences
about how changes in energy regulation and its impairment can have a
modulatory impact on brain and retinal functions ranging from altered
synaptic plasticity and network formation to developmental changes.
Energy imbalance can also significantly alter the coupling of neuronal
cells with glial cells and oligodendrocytes [4]. Glucose is recognised as
the primary energy source but lactate, pyruvate and beta-
hydroxybutyrate are some of the other substrates that mediate ATP
generation in the CNS. Various growth factors and neurotropins play
essential role in the maintenance of effective energy equilibrium in the
neuronal tissues by their regulatory actions on glycolytic pathway,
mitochondrial function as well as cellular uptake of energy substrates
[5,6]. Neuronal energy demands are met by ATP production which in
turn is linked to optimal energy substrate endocytosis and expenditure.
Receptor mediated glucose uptake by neurons is tightly linked to
activation of IR/IGF1R, EGFR and neurotropin pathways [7,8]. Their
downstream effectors like PI3K/ Akt, MEK/Erk1/2 and PLCγ/ PKC/
NFκB in turn regulate various enzymatic catalytic steps involved in
ATP generation [9-11]. Cellular signalling pathways extensively cross-
talk with enzymes responsible for ATP production in the cytoplasm
and mitochondria and regulate their activity through
phosphorylation / dephosphorylation cascades involving various
receptor and non-receptor phosphatases and kinases [12,13]. This line
of research using cell biology and various animal models has helped to
identify the mechanisms underlying regulation of metabolic
machinery by the cellular signalling pathways. Human studies have
also helped understand the association of brain cognitive and
behavioural changes with metabolic disorders that primarily affect
energy metabolism such as diabetes. Recent studies further suggest
that modulating calorie intake helps preserve brain function and
improve cognition and reduce the risk of various neurodegenerative
disorders [14]. Nutritional changes to promote ketogenesis by altering
the dietary ratio of protein / carbohydrate and lipids have also been
shown to exert neuroprotective effects by providing higher quantities
of ATP and phosphocreatine and inducing an increase in the
mitochondrial number in the cells [15].
Other studies have reported various pharmacologically bioactive
compounds such as Tropomyosin kinase receptor B (TrkB) agonists
that help to modulate or preserve brain and retinal function.
Modulators of neurotropin signalling such as 7,8 dihydroxyflavone and
Deoxygedunin can activate Akt and Erk pathways which in turn
modulate the activity of various phosphatases and kinases that play a
role in cellular energy metabolism [16,17]. Apart from
pharmacological approaches, gene therapy to modulate the
neurotropin signalling can be used to target key enzymes involved in
ATP generation as well as their upstream regulators and downstream
effectors. Genetic approaches have already reached clinical practice in
retinal disorders using AAV therapy in Leber’s Congenital Amaurosis
(LCA) [18]. The great advantage in using AAV is that it poses minimal
antigenic responses and ensures long-term expression of the gene in
the neuronal cells. In this regard, AAV9 serotype is particularly of the
essence as it can cross the blood brain barrier following intravenous
administration which has been the major challenge in the field [19].
Transgene expression in the neurons using specific promoters can be
helpful to understand mechanisms underlying various CNS diseases,
physiological processes and develop therapeutic tools and approaches.
The effects of such gene therapy treatments can be investigated in
animal model of disease with specific genes upregulated or knocked
down. Similar studies can also be carried out in the transgenic animals
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and tissue specific expression modulation using cre-lox or CRISPR
technologies with inducible promoter expression system [20-22]. With
the advent of new approaches and instrumentation we are now in a
position to study the whole brain changes in a three dimensional
network using techniques like small animal magnetic resonance
imaging (MRI) and positron emission tomography (PET) scanning in
vivo and CLARITY technique in vitro to study cellular resolution of
the whole connectome [23,24]. Bioinformatics and molecular
modelling studies can also be of help to identify novel interacting
partners and binding sites [25]. These studies will help to carry out
unbiased research on synaptic and neuronal network and identify
region specific changes moderated by the ageing / disease processes or
their modulation by pharmacological or therapeutic approaches.
Altogether, improved understanding of energy homeostasis in brain
mediated through the network of various cellular signalling pathways
using cutting-edge technologies has enormous implications in
understanding the pathophysiological mechanisms and improved
therapeutic targeting.
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